sharetrader
Page 2043 of 2125 FirstFirst ... 1043154319431993203320392040204120422043204420452046204720532093 ... LastLast
Results 20,421 to 20,430 of 21246
  1. #20421
    Senior Member
    Join Date
    Sep 2002
    Posts
    545

    Default

    Quote Originally Posted by t.rexjr View Post
    If it were clinicians then it would've said that as that surely...? Mind you each clinician isn't likely to be doing multiple tests a month so whether a user is patient or clinician probably neither here nor there...

    Of course a "user" could also be both patient and clinician...
    Indeed... Could be either or both... Maybe anyone who orders a test...? I do think clinicians with many patients would likely be ordering more than one test per month... Very unlikely that an individual patient would...

    Strange wording regardless - they have previously always referred to clinicians and patients....

  2. #20422
    Senior Member
    Join Date
    Mar 2010
    Posts
    964

    Default

    Yes that "500 monthly users" line a bit hard to fathom. Can't be throughput, that'd be awful.

    The "dramatically increased the size of it's presence in Main Exhibition Hall" means it had a 20'x10' in-line booth this year. Exciting.
    But I can't see that there was any yabber about Cxbladder in any of the presentations? So no significant swing in adoption, just nice chats?

    Just suggesting they got the warm fuzzies a bit of an odd announcement to specifically bring to market this close to results I thought?

  3. #20423
    Senior Member pierre's Avatar
    Join Date
    Jul 2004
    Location
    Hawkes Bay, New Zealand
    Posts
    1,105

    Default

    Rather than speculate as to what PEB means by "500 monthly users" I have just emailed the company asking them to clarify the statement. I will publish an update when they respond.

  4. #20424
    AWOL
    Join Date
    Sep 2012
    Location
    Vacation
    Posts
    2,782

    Default

    What should be maybe considered is that 500 "users" are not following AUA guidelines these days due to the overwhelming need for AUA to up their act after 2 years of covid related non events.

  5. #20425
    AWOL
    Join Date
    Sep 2012
    Location
    Vacation
    Posts
    2,782

    Default

    Quote Originally Posted by BigBob View Post
    Indeed... Could be either or both... Maybe anyone who orders a test...? I do think clinicians with many patients would likely be ordering more than one test per month... Very unlikely that an individual patient would...

    Strange wording regardless - they have previously always referred to clinicians and patients....
    Individual patients would have a physician/ urologist attached somewhere in the process for the test results.

    A patient in home test would require physician/ urologist authorization in order for billing and test results to take place.

    Its not like you can rush out and get a 6 pack of tests at Walmart.
    Last edited by Minerbarejet; 19-05-2022 at 01:09 PM.

  6. #20426
    Senior Member pierre's Avatar
    Join Date
    Jul 2004
    Location
    Hawkes Bay, New Zealand
    Posts
    1,105

    Default

    I received the following reply from PEB to my request for clarification of the term "500 monthly users" in their recent communication to shareholders following the AUA meeting:

    "The “users” we refer to is the ordering clinician, of which most are US based. Our Account Executive team in the US are focused on increasing test adoption by urologists, who are the users of the test to assist in the assessment of their patients."


    That's positive though, of course, the next question is: What is the average number of tests per month ordered by each clinician? Hopefully that information might be revealed in the FY report at month-end.

    I did a Google search and found that in 2019 the US urologist population totaled around 13,000. That means only ~4% of them are using Cxbladder so there's plenty of room for growth.

  7. #20427
    Member
    Join Date
    Dec 2019
    Location
    Auckland
    Posts
    485

    Default

    Thanks for researching and sharing that reply Pierre

  8. #20428
    AWOL
    Join Date
    Sep 2012
    Location
    Vacation
    Posts
    2,782

    Default

    Quote Originally Posted by pierre View Post
    I received the following reply from PEB to my request for clarification of the term "500 monthly users" in their recent communication to shareholders following the AUA meeting:

    "The “users” we refer to is the ordering clinician, of which most are US based. Our Account Executive team in the US are focused on increasing test adoption by urologists, who are the users of the test to assist in the assessment of their patients."


    That's positive though, of course, the next question is: What is the average number of tests per month ordered by each clinician? Hopefully that information might be revealed in the FY report at month-end.

    I did a Google search and found that in 2019 the US urologist population totaled around 13,000. That means only ~4% of them are using Cxbladder so there's plenty of room for growth.
    Thanks Pierre - good news

  9. #20429
    AWOL
    Join Date
    Sep 2012
    Location
    Vacation
    Posts
    2,782

    Default

    Quote Originally Posted by pierre View Post
    I received the following reply from PEB to my request for clarification of the term "500 monthly users" in their recent communication to shareholders following the AUA meeting:

    "The “users” we refer to is the ordering clinician, of which most are US based. Our Account Executive team in the US are focused on increasing test adoption by urologists, who are the users of the test to assist in the assessment of their patients."


    That's positive though, of course, the next question is: What is the average number of tests per month ordered by each clinician? Hopefully that information might be revealed in the FY report at month-end.

    I did a Google search and found that in 2019 the US urologist population totaled around 13,000. That means only ~4% of them are using Cxbladder so there's plenty of room for growth.
    By that I take it they mean that 500 ordering clinicians are using cxbladder at least once a month so at a minimum we have 500 times 12 = 6000 tests times 1000NZd for a minimum of 6,000,000 per annum with just one patient tested per month.
    One patient a week by the 500 mentioned would produce 24,000,000.

    Think we might be in for a surprise this week.

  10. #20430
    Member
    Join Date
    May 2009
    Location
    Auckland
    Posts
    176

    Default

    Quote Originally Posted by Minerbarejet View Post
    By that I take it they mean that 500 ordering clinicians are using cxbladder at least once a month so at a minimum we have 500 times 12 = 6000 tests times 1000NZd for a minimum of 6,000,000 per annum with just one patient tested per month.
    One patient a week by the 500 mentioned would produce 24,000,000.

    Think we might be in for a surprise this week.
    What about taking FY22H1 data for the estimate :-)

    In FY22H1, there are 9,192 commercial tests.
    So, each user have 3 tests per month in average.

    9,192 ÷ 6 ÷ 500 = 3.06 test per user per month.

    Let's assume 3 to 4 tests per month per user is a reasonable range for the entire financial year.

    We have 18,000 to 24,000 commercial test in FY22.

    500 × 3 × 12 = 18,000
    500 × 4 × 12 = 24,000

    Please note that the commercial test number in FY21 was 12,975.
    Last edited by zs_cecil; 21-05-2022 at 06:58 PM.

Tags for this Thread

Bookmarks

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •